ANCA阴性寡免疫坏死性肾小球肾炎:病例系列及新临床分型
该病例系列纳入法国19个肾内科中心2006年8月至2018年12月诊断的74例ANCA阴性寡免疫坏死性肾小球肾炎患者,中位年龄69岁。临床病理特征包括高频率肾外表现(54%)、肾病综合征(32%)和内皮细胞增生(31%)。提出感染相关(12%)、恶性肿瘤相关(8%)和原发性(77%)三种亚型,中位随访28个月后38%死亡、27%进展至肾衰竭。
要点
- ANCA阴性PING罕见但严重,肾外表现和肾病综合征常见。
- 新临床分型:感染相关、恶性肿瘤相关和原发性三类。
- 即使接受免疫抑制治疗,死亡和肾衰竭风险仍高。
核心结论
- ANCA阴性PING中感染和恶性肿瘤相关形式构成独特临床亚群,新分型有助于指导管理。
- 该病仍是严重血管炎,尽管接受免疫抑制治疗,发病率和死亡率仍高。
研究设计与样本
- 病例系列研究,纳入法国19个肾内科中心2006年8月至2018年12月诊断的74例ANCA阴性PING患者。
- 回顾医疗文件,肾活检由对诊断不知情的病理学家集中复核。
主要发现
- 诊断时中位年龄69岁(IQR 61-76)。
- 肾外表现频率54%,肾病综合征32%,内皮细胞增生31%。
- 亚型分布:感染相关9例(12%),恶性肿瘤相关6例(8%),原发性57例(77%)。
- 原发性PING诱导治疗主要包括糖皮质激素56例(98%)、环磷酰胺37例(65%)、利妥昔单抗5例(9%)。
- 中位随访28个月,28例(38%)死亡,20例(27%)发生肾衰竭(eGFR<15mL/min/1.73m2),11例(21%)复发(原发9例,恶性肿瘤相关2例)。
临床怎么用
- 对ANCA阴性PING应评估感染和恶性肿瘤相关病因以指导分型管理。
- 原发性PING常用糖皮质激素联合环磷酰胺或利妥昔单抗诱导,需警惕高死亡和肾衰竭风险。
局限性
- 回顾性研究且患者数量有限。
- 未行电子显微镜确认肾小球免疫沉积物缺失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Pauci-immune necrotizing glomerulonephritis (PING) is usually associated with the presence of antineutrophil cytoplasmic antibodies (ANCA). However, a minority (2%-3%) of patients with PING do not have detectable ANCA. We assessed the clinical spectrum and outcome of patients with ANCA-negative PING. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: 74 patients with ANCA-negative PING diagnosed in 19 French nephrology centers between August 2006 and December 2018 were included in the series. Patients' medical files were reviewed, and kidney biopsies were centrally reexamined by pathologists who were masked to the diagnosis. FINDINGS: Median age at diagnosis was 69 (IQR, 61-76) years. The clinical and pathological features were remarkable for a high frequency of extrarenal manifestations (54%), nephrotic syndrome (32%), and endocapillary hypercellularity (31%). Three main subtypes of ANCA-negative PING were observed: infection-associated (n=9[12%]), malignancy-associated (n=6[8%]), and primary (n=57[77%]). For patients with primary PING, induction treatment included mainly corticosteroids (n=56[98%]), cyclophosphamide (n=37[65%]), and rituximab (n=5[9%]). Maintenance treatment consisted mainly of corticosteroids (n=42[74%]), azathioprine (n=18[32%]), and mycophenolate mofetil (n=11[19%]). After a median follow-up period of 28 months, 28 (38%) patients had died and 20 (27%) developed kidney failure (estimated glomerular filtration rate<15mL/min/1.73m2). Eleven (21%) patients (9 with primary and 2 with malignancy-associated PING) relapsed. LIMITATIONS: Retrospective study and limited number of patients; electron microscopy was not performed to confirm the absence of glomerular immune deposits. CONCLUSIONS: Within the spectrum of ANCA-negative PING, infection and malignancy-associated forms represent a distinct clinical subset. This new clinical classification may inform the management of ANCA-negative PING, which remains a severe form of vasculitis with high morbidity and mortality rates despite immunosuppressive treatments.
引用
- Ronsin C, Georges M, Chapelet-Debout A, et al. ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification. Am J Kidney Dis. 2021. PMID: 34119564. doi:10.1053/j.ajkd.2021.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。